Evidence map›Paper›PMID 31327626›Full record

ArticleParkinsonism & related disorders2019

Earlier age of onset in multiple system atrophy with smoking and heavy alcohol use.

Lauren Jackson, Elizabeth A Coon, J Eric Ahlskog, James H Bower, Paola Sandroni, Eduardo E Benarroch, Jay N Mandrekar, Phillip A Low, Wolfgang Singer

Open access · greenAbstract read
In one paragraph

Article in Parkinsonism & related disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Occupational histories in neuropathologically confirmed multiple system atrophy.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Article
  4. Multiple system atrophy.Nature reviews. Disease primers · 2022
    Review
  5. Lower Vitamin B12 Level at Multiple System Atrophy Diagnosis Is Associated With Shorter Survival.Movement disorders : official journal of the Movement Disorder Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lauren JacksonDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Elizabeth A CoonDepartment of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: coon.elizabeth@mayo.edu.
J Eric AhlskogDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
James H BowerDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Paola SandroniDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Eduardo E BenarrochDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Jay N MandrekarDepartment of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Phillip A LowDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Wolfgang SingerDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Studies on Diagnosis, Pathophysiology, and Treatment of Autonomic Failure in MSAP01NS044233 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LOW, PHILLIP A · 2003 to 2014
$12.4M
Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LOW, PHILLIP A · 2009 to 2018
$11.6M
Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic ApproachR01NS092625 · NINDS · MAYO CLINIC ROCHESTER · PI SINGER, WOLFGANG, VEMURI, PRASHANTHI · 2015 to 2025
$6.6M
Differential Approach to the Postural Tachycardia SyndromeK23NS075141 · NINDS · MAYO CLINIC ROCHESTER · PI SINGER, WOLFGANG · 2012 to 2016
$872k
Phase 1 Study of Autologous Mesenchymal Stem Cell in Multiple System AtrophyR01FD004789 · FDA · MAYO CLINIC ROCHESTER · PI LOW, PHILLIP A · 2014 to 2016
$600k
FDA HHS R01 FD004789NCATS NIH HHS UL1 TR000135NINDS NIH HHS K23 NS075141NINDS NIH HHS P01 NS044233NINDS NIH HHS R01 NS092625NINDS NIH HHS U54 NS065736
6 · The paper itself

Abstract

objectiveTo determine whether smoking or alcohol use impacts the age of onset and disease duration in multiple system atrophy (MSA).

methodsAll patients diagnosed with MSA at Mayo Clinic, Rochester between 1998 and 2012 completed standardized questionnaires surveying smoking and alcohol use at the time of presentation.

resultsOf 551 patients with smoking and alcohol use data, 281 were past or present smokers with age of onset of 60.76 years compared to 62.97 years in controls (p = 0.0144). Age of onset in the 87 heavy alcohol users was 56.87 years compared to 62.97 years in controls (p = 0.0133). There was no difference in disease duration for smokers (p = 0.2758) or heavy alcohol users (p = 0.4820) compared to controls.

conclusionOur findings show that smoking history and/or heavy alcohol use is associated with younger age of onset in MSA but do not influence survival.

Indexed as

AgedAged, 80 and overAge of OnsetAlcoholismAtaxiaComorbidityFemaleHumansMaleMiddle AgedMultiple System AtrophySmokingAlcoholAtaxiaMultiple system atrophyParkinsonismSmoking

Identifiers

PMID31327626
PMCPMC6779510
OpenAlexW2962250467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.